Department of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.
Circ Arrhythm Electrophysiol. 2023 Nov;16(11):e012191. doi: 10.1161/CIRCEP.123.012191. Epub 2023 Oct 25.
The cause of hypertrophic cardiomyopathy (HCM) in the young is highly varied. Ventricular preexcitation (preexcitation) is well recognized, yet little is known about the specificity for any cause and the characteristics of the responsible accessory pathways (AP).
Retrospective cohort study of patients <21 years of age with HCM/preexcitation from 2000 to 2022. The cause of HCM was defined as isolated HCM, storage disorder, metabolic disease, or genetic syndrome. Atrioventricular AP (true AP) were distinguished from fasciculoventricular fibers (FVF) using standard invasive electrophysiology study criteria. AP were defined as high risk if any of the following were <250 ms: shortest preexcited RR interval in atrial fibrillation, shortest paced preexcited cycle length, or anterograde AP effective refractory period.
We identified 345 patients with HCM and 28 (8%) had preexcitation (isolated HCM, 10/220; storage disorder, 8/17; metabolic disease, 5/19; and genetic syndrome, 5/89). Six (21%) patients had clinical atrial fibrillation (1 with shortest preexcited RR interval <250 ms). Twenty-two patients underwent electrophysiology study which identified 23 true AP and 16 FVF. Preexcitation was exclusively FVF mediated in 8 (36%) patients. Five (23%) patients had AP with high-risk conduction properties (including ≥1 patient in each etiologic group). Multiple AP were seen in 8 (36%) and AP plus FVF in 10 (45%) patients. Ablation was acutely successful in 13 of 14 patients with recurrence in 3. One procedure was complicated by complete heart block after ablation of a high-risk midseptal AP. There were significant differences in QRS amplitude and delta wave amplitude between groups. There were no surface ECG features that differentiated AP from FVF.
Young patients with HCM and preexcitation have a high likelihood of underlying storage disease or metabolic disease. Nonisolated HCM should be suspected in young patients with large QRS and delta wave amplitudes. Surface ECG is not adequate to discriminate preexcitation from a benign FVF from that secondary to potentially life-threatening AP.
肥厚型心肌病(HCM)在年轻人中的病因多种多样。心室预激(预激)是众所周知的,但对于任何病因的特异性以及相关旁路(AP)的特征知之甚少。
对 2000 年至 2022 年间患有 HCM/预激的<21 岁患者进行回顾性队列研究。HCM 的病因定义为孤立性 HCM、储存障碍、代谢性疾病或遗传综合征。房室旁路(真 AP)与间隔纤维(FVF)的区分采用标准的侵入性电生理研究标准。如果以下任何一项<250ms,则将 AP 定义为高风险:心房颤动时最短的预激 RR 间期、最短的程控预激周期长度或顺行 AP 有效不应期。
我们共确定了 345 例 HCM 患者,其中 28 例(8%)存在预激(孤立性 HCM,10/220;储存障碍,8/17;代谢性疾病,5/19;遗传综合征,5/89)。6 例(21%)患者存在临床心房颤动(1 例最短预激 RR 间期<250ms)。22 例患者行电生理检查,共发现 23 例真 AP 和 16 例 FVF。8 例(36%)患者的预激完全由 FVF 介导。5 例(23%)患者的 AP 具有高危传导特性(每个病因组均至少 1 例)。8 例(36%)患者存在多个 AP,10 例(45%)患者存在 AP 合并 FVF。14 例患者中有 13 例消融即刻成功,其中 3 例复发。1 例高风险中隔 AP 消融后出现完全性心脏阻滞。各组间 QRS 波振幅和 delta 波振幅存在显著差异。体表心电图无特征可区分 AP 与良性 FVF。
患有 HCM 和预激的年轻患者极有可能存在潜在的储存障碍或代谢性疾病。对于 QRS 波振幅和 delta 波振幅较大的年轻患者,应怀疑非孤立性 HCM。体表心电图不足以区分预激与良性 FVF,也不足以区分良性 FVF 与可能危及生命的 AP。